Investor Intelligence
Your portfolio’s next big idea. Each week, our analysts and leading Wall-Street experts provide in-depth analysis that dives deep on a company, opportunity or trend in markets. Brought to you by Finimize, the #1 financial information platform for modern investors.
Investor Intelligence
Why A Company Revolutionising Organ Care Could Be The Hottest Growth Stock Right Now
Donated organs don’t stay viable outside a human body for very long. And because they have to be a match for a potential recipient – in terms of size, genetics, and geographical location – most end up wasted rather than transplanted, despite an overwhelming need for them.
There’s always been a complex web of problems in this part of healthcare, from the medical to the logistical. But a company called TransMedics has been working to solve the ones it can. And now its big innovation – the Organ Care System, a portable device that replicates an organ’s natural, functioning environment – has been approved by the FDA. And that makes TransMedics’s stock worth looking into.
Today, Finimize analyst Russell Burns sits down with Guy Gardener to look at exactly how they’ve changed the game in organ care, their growth story for 2025, how this kind of investment could fit into your portfolio, and much more.
Try Finimize Premium
